Status:
RECRUITING
30 Day Insulin Balance Metabolic Health Optimization Protocol
Lead Sponsor:
Efforia, Inc
Conditions:
Insulin
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Explore how a dietary supplement can help support healthy insulin levels and its impact on weight, fatigue, and sugar cravings. The Insulin Balance Formula and Hormetics Weight Optimization System is ...
Detailed Description
Treatment activities: Daily Activity: Take 3 capsules of the Insulin Balance Supplement daily, ideally 1 capsule before each meal or all at once for convenience. Begin with 1 capsule to assess tolera...
Eligibility Criteria
Inclusion Criteria:
- Adults 18+ who are generally healthy
- Ability to read and comprehend English
- Ability to willfully consent and follow study procedures and tasks
Exclusion Criteria:
- Individuals with Known Allergies
- Pregnant or Nursing Individuals
- Individuals with Insulin Disorders
- Individuals with GI Disorders
- Individuals with Mental Health Conditions
- Individuals with Sleep Disorders
- Individuals on Medication
- Athletes under Specific Regulations
- Individuals Sensitive to Fatigue
Key Trial Info
Start Date :
October 21 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 21 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07478497
Start Date
October 21 2025
End Date
October 21 2026
Last Update
March 17 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Efforia
New York, New York, United States, 10003